Orchids are one of the most significant plants that have ecologically adapted to every habitat on earth. Orchids show a high level of variation in their floral morphologies, which makes them popular as ornamental plants in the global market. Floral scent and color are key traits for many floricultural crops. Volatile organic compounds (VOCs) play vital roles in pollinator attraction, defense, and interaction with the environment. Recent progress in omics technology has led to the isolation of genes encoding candidate enzymes responsible for the biosynthesis and regulatory circuits of plant VOCs. Uncovering the biosynthetic pathways and regulatory mechanisms underlying the production of floral scents is necessary not only for a better understanding of the function of relevant genes but also for the generation of new cultivars with desirable traits through molecular breeding approaches. However, little is known about the pathways responsible for floral scents in orchids because of their long life cycle as well as the complex and large genome; only partial terpenoid pathways have been reported in orchids. Here, we review the biosynthesis and regulation of floral volatile compounds in orchids. In particular, we focused on the genes responsible for volatile compounds in various tissues and developmental stages in Cymbidium orchids. We also described the emission of orchid floral volatiles and their function in pollination ecology. Taken together, this review will provide a broad scope for the study of orchid floral scents.
We measure the local harmonic generation from an YBa 2 Cu 3 O 7-δ (YBCO) bi-crystal grain boundary to examine the local Josephson nonlinearities. Spatially resolved images of second and third harmonic signals generated by the grain boundary are shown. The harmonic generation and the vortex dynamics along the grain boundary are modeled with the Extended Resistively Shunted Josephson (ERSJ) array model, which shows reasonable agreement with the experimental data. The model also gives qualitative insight into the vortex dynamics induced in the junction by the probing current distribution. A characteristic nonlinearity scaling current density J NL ~ 5 10 5 . 1 × A/cm 2 for the Josephson nonlinearity is also extracted.
This assignment applies to all translations of the Work as well as to preliminary display/posting of the abstract of the accepted article in electronic form before publication. If any changes in authorship (order, deletions, or additions) occur after the manuscript is submitted, agreement by all authors for such changes must be on file with the Publisher. An author's name may be removed only at his/her written request. (Note: Material prepared by employees of the US government in the course of their official duties cannot be copyrighted.
A novel botulinum neurotoxin type A (DWP450; Daewoong Pharmaceutical, Seoul, Korea) has recently been introduced for the treatment of facial wrinkles. The efficacy of this agent has previously been demonstrated in an in vivo study using an electrophysiological protocol in a rat model. To compare the efficacy and safety of DWP450 with onabotulinumtoxinA (OBoNT) for use in the treatment of glabellar lines, we performed a multicenter, double-blind, randomized, active-controlled trial comparing DWP450 and OBoNT (Allergan Inc., Irvine, CA, USA). A total of 268 subjects with moderate to severe glabellar lines were randomized at a 1:1 ratio. Each patient received treatment with 20 U of study medication. Maximum frown responder rates at week 4 were measured to analyze the primary efficacy endpoint. To evaluate secondary efficacy endpoints, response rates were measured at weeks 8, 12, and 16, at maximum frown and rest. Specifically, responder rates at both maximum frown and at rest were assessed based on clinical photography. Subject degree of satisfaction and self-assessed rate of response were also measured. Adverse events (AEs) were documented to evaluate safety. Responder rate by physician-rating severity at maximal contraction at week 4 was 93.89% in the DWP450 group and 88.64% in OBoNT group. As the lower limit of the 97.5% one-sided confidence interval (-1.53%) surpassed the -15% threshold, we determined that DWP450 was not inferior to OBoNT. For the secondary efficacy endpoint analyses, no significant differences were observed between the two groups for any variable at any point in time. The incidences of AEs were similar for the two groups. Most of AEs were considered mild. DWP450 and OBoNT were comparable in efficacy and safety in the treatment of glabellar lines.
The purpose of this study was to investigate the effect of volatile fatty acid concentration on anaerobic degradation rate of food waste leachate in the anaerobic digestion facilities. The anaerobic digestion facilities treating food waste leachate (FWL), codigestion with food leachate and animal manure (A-MIX), and codigestion with food waste leachate and sewage sludge (S-MIX) were selected for this study. In accordance with the regulation under Wastes Control Act in South Korea, the guideline of volatile solid removal rate for anaerobic digestion facility is set as 65% for anaerobic degradation efficiency. Highest volatile solids removal rates were achieved from FWL (63.5%) than A-MIX (56.4%) and S-MIX (41.2%). Four out of eight FWLs met the guidelines. The concentration of volatile fatty acids, therefore, was analyzed to determine the relationship with volatile solid removal rate. The results showed that, in order to meet the Korean guideline of 65% volatile solid removal rate, volatile fatty acid concentrations should remain below 4,000 mg/L on the field anaerobic digestion facilities treating FWL. Volatile fatty acid concentrations should be used along with others as an operational parameter to control and manage the anaerobic digestion process.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.